STAT3 and myeloproliferative neoplasm: MPN-specific oncogene mutations such as JAK2V617F and MPLW515L stimulate the JAK/STAT3 pathway to enhance inflammatory cytokine production by autocrine and paracrine mechanisms, promoting the growth of the other MPN cells but suppressing the growth of normal cells.